Lupin has announced the launch of Tydemy tablets – the generic equivalent of Bayer's Safyral, a birth control drug. The pharma major stated that it had received US Food and Drug Administration's (USFDA) approval in December last year.

Tydemy (drospirenone, ethinyl estradiol, levomefolate calcium, 3mg/0.03mg/0.451mg & levomefolate calcium, 0.451mg) is the generic version of Safyral, which is indicated for use by women to prevent pregnancy and raise folate levels in women who choose to use oral contraceptives.

This combination formulation had an annual sale of approximately USD 22mn in the US in 2017. Apart from Lupin, there seems only one player in this market.  – IIFL 

10 Diagnostic Imaging Trends for 2018


Digital version